PlainRecalls
FDA Drug Critical Class I Ongoing

Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1

Reported: October 22, 2025 Initiated: September 16, 2025 #D-0015-2026

Product Description

Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1

Reason for Recall

Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.

Details

Units Affected
853/500 mL bags
Distribution
Nationwide in the USA
Location
Minneapolis, MN

Frequently Asked Questions

What product was recalled?
Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1. Recalled by IntegraDose Compounding Services LLC. Units affected: 853/500 mL bags.
Why was this product recalled?
Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 22, 2025. Severity: Critical. Recall number: D-0015-2026.